1. Home
  2. CHRS Annual Meeting
  3. Learning Objectives

Learning Objectives

Overall Learning Objectives 

 At the end of this meeting, participants will be able to: 

  • Identify concepts, facilitate collaboration and satisfy personal education goals in the field of cardiac arrhythmias from leading Canadian and International experts. (Medical Expert, Collaborator, Scholar, Leader)
  • Apply the latest advances in the field of cardiac arrhythmias, including prevention of arrhythmias, inherited arrhythmic disorders, cardiac implantable electronic devices, and catheter ablation. (Medical Expert, Collaborator, Scholar, Leader)
  • Demonstrate a balanced perspective on prevention and management of cardiac arrhythmias from a field of experts including clinician experts, clinician researchers, basic scientists, and allied health professionals. (Medical Expert, Collaborator, Scholar, Leader)

Session Specific Learning Objectives

Friday September 13, 2024

SESSION 1: FELLOWS & ALLIED HEALTH PROFESSIONAL PROGRAM 

Following this session, participants will be able to: 

  • Develop an approach to interpretation of complex EP tracings and complex implantation techniques (CRT-LBB and others). (Medical Expert, Collaborator, Scholar, Leader) 
  • Participate in Fellows Case Presentations sessions addressing basic and advanced concepts in the field of cardiac arrhythmias. (Medical Expert, Collaborator, Scholar, Leader) 

Saturday September 14, 2024 

SESSION 1: WHAT’S NEW IN 2024?  

Following this session, participants will be able to: 

  • Recognize the impact and applications of AI in EP. (Medical Expert, Collaborator, Scholar, Leader) 
  • Integrate the new data on HF and CRT/LBB in the new area of the optimize medical treatment of HF. (Medical Expert, Collaborator, Scholar, Leader) 
  • Recognize the impact of environmental factors in EP and vice versa. (Medical Expert, Collaborator, Scholar, Leader) 

SESSION 2: DEVICE SESSION (Joint Session EHRA/CHRS)   

Following this session, participants will be able to: 

  • Review randomized clinical trial data supporting the use of OAC for patients with SCAF and identify patients' subgroups where OAC is most likely to be effective. (Medical Expert, Collaborator, Scholar, Leader) 
  • Estimate stroke and bleeding risk in patients with device detected AHRE. (Medical Expert, Collaborator, Scholar, Leader) 
  • Understand the controversy around the net benefit of anticoagulation based on the results of two recent RCT-s. (Medical Expert, Collaborator, Scholar, Leader) 
  • Identify patients who should benefit of anticoagulation in case of subclinical AF episodes. (Medical Expert, Collaborator, Scholar, Leader) 
  • Describe the relation in between transvenous leads and tricuspid regurgitation, manage patients with tricuspid regurgitation and CIEDS in term of treatment of the TR and the device. (Medical Expert, Collaborator, Scholar, Leader) 

SESSION 3: GENETICS SESSION   

Following this session, participants will be able to: 

  • Identify patients who should benefit of genetic testing in atrial fibrillation. (Medical Expert, Collaborator, Scholar, Leader) 
  • Review cardiac involvement in different neuromuscular diseases and their particular management. (Medical Expert, Collaborator, Scholar, Leader) 
  • Recognize pathology and patients with higher risks of arrhythmias/sudden cardiac death during efforts. (Medical Expert, Collaborator, Scholar, Leader) 

SESSION 4: INDUSTRY PRESENTATION: WHAT IS IN THE PIPELINE?    

 Opportunity to present latest and new technologies.  

SESSION 5: ABLATION SESSION (Joint Session HRS/CHRS)    

 Following this session, participants will be able to: 

  • Identify and recognize patients and signs to higher risks of arrhythmias and sudden cardiac death in the patients with mitral valve prolapse based on the EHRA expert consensus. (Medical Expert, Collaborator, Scholar, Leader) 
  • Identify how reducing and trend to zero fluoroscopy for ablation in EP. (Medical Expert, Collaborator, Scholar, Leader) 
  • Describe sex differences in AF presentation, risk factors, and management. (Medical Expert, Collaborator, Scholar, Leader) 
  • Review pulsed field ablation developments for catheter ablation of atrial fibrillation. (Medical Expert, Collaborator, Scholar, Leader)